Pulmonx (LUNG) News Today $3.20 +0.24 (+8.11%) Closing price 04:00 PM EasternExtended Trading$3.22 +0.02 (+0.78%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUNG Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare ConferenceMay 28 at 4:18 PM | globenewswire.comPulmonx Co. (NASDAQ:LUNG) Shares Sold by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. lessened its stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 72.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 83,370 shares of the company's stock after sellingMay 20, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Receives $12.07 Consensus Price Target from AnalystsMay 20, 2025 | americanbankingnews.comPulmonx Co. (NASDAQ:LUNG) Given Average Recommendation of "Moderate Buy" by BrokeragesPulmonx Co. (NASDAQ:LUNG - Get Free Report) has received an average recommendation of "Moderate Buy" from the nine ratings firms that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and seven have given a buy rating toMay 19, 2025 | marketbeat.com82,070 Shares in Pulmonx Co. (NASDAQ:LUNG) Purchased by Mercer Global Advisors Inc. ADVMercer Global Advisors Inc. ADV bought a new position in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 82,070 shares of the company's stock, valued at approximately $557,00May 15, 2025 | marketbeat.comDeerfield Management Company L.P. Series C Purchases New Position in Pulmonx Co. (NASDAQ:LUNG)Deerfield Management Company L.P. Series C purchased a new position in Pulmonx Co. (NASDAQ:LUNG - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 1,534,763 shares of the company's stock, valuedMay 10, 2025 | marketbeat.comPulmonx Corporation (NASDAQ:LUNG) Q1 2025 Earnings Call TranscriptMay 6, 2025 | msn.comD. Boral Capital Reaffirms Buy Rating for Pulmonx (NASDAQ:LUNG)D. Boral Capital restated a "buy" rating and set a $17.00 price objective on shares of Pulmonx in a report on Thursday.May 3, 2025 | marketbeat.comPulmonx (LUNG) Expected to Announce Quarterly Earnings on WednesdayPulmonx (NASDAQ:LUNG) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-pulmonx-co-stock/)May 2, 2025 | marketbeat.comPulmonx to Present at the Bank of America Securities 2025 Health Care ConferenceMay 1, 2025 | globenewswire.comQ1 2025 Pulmonx Corp Earnings CallMay 1, 2025 | finance.yahoo.comBoothbay Fund Management LLC Sells 63,206 Shares of Pulmonx Co. (NASDAQ:LUNG)Boothbay Fund Management LLC decreased its holdings in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 22.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 212,980 shares of the company's stock after selling 63,206 shares durMay 1, 2025 | marketbeat.comPulmonx Corp (LUNG) Q1 2025 Earnings Call Highlights: Strong International Growth Amid Domestic ...May 1, 2025 | uk.finance.yahoo.comPulmonx projects 20% long-term growth amid expanded initiatives and $12B market opportunityMay 1, 2025 | msn.comPulmonx Corporation (LUNG) Q1 2025 Earnings Call TranscriptApril 30, 2025 | seekingalpha.comPulmonx Reports First Quarter 2025 Financial ResultsApril 30, 2025 | globenewswire.comPulmonx Co. (NASDAQ:LUNG) Shares Purchased by Renaissance Technologies LLCRenaissance Technologies LLC raised its holdings in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 38.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 220,510 shares of the company's stock after acquiring an additional 61,500April 30, 2025 | marketbeat.comPulmonx's Earnings OutlookApril 29, 2025 | benzinga.comBirchview Capital LP Purchases Shares of 51,000 Pulmonx Co. (NASDAQ:LUNG)Birchview Capital LP acquired a new position in Pulmonx Co. (NASDAQ:LUNG - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 51,000 shares of the company's stock, valued at approximately $346,000. Birchview Capital LPApril 28, 2025 | marketbeat.comRock Springs Capital Management LP Purchases 80,851 Shares of Pulmonx Co. (NASDAQ:LUNG)Rock Springs Capital Management LP increased its holdings in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 11.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 772,151 shares of the companApril 23, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Pulmonx Co. (NASDAQ:LUNG - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eight research firms that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and six have issued a buy reApril 23, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Stock Holdings Increased by Altium Capital Management LLCAltium Capital Management LLC grew its position in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 63.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 815,000 shares of the company's stock after purchasing anApril 20, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Shares Sold by JPMorgan Chase & Co.JPMorgan Chase & Co. cut its stake in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 27.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 768,430 shares of the company's stock after selling 287,09April 20, 2025 | marketbeat.comTrexquant Investment LP Purchases 78,343 Shares of Pulmonx Co. (NASDAQ:LUNG)Trexquant Investment LP boosted its position in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 510.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 93,700 shares of the company's stock after pApril 14, 2025 | marketbeat.comFranklin Resources Inc. Decreases Position in Pulmonx Co. (NASDAQ:LUNG)Franklin Resources Inc. decreased its stake in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 17.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 576,273 shares of the company's stock after selling 124,116 shares during the quarter. FranklinApril 14, 2025 | marketbeat.com151,200 Shares in Pulmonx Co. (NASDAQ:LUNG) Acquired by Norges BankNorges Bank purchased a new position in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 151,200 shares of the company's stock, valued at approximately $April 14, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Pacific Biosciences (PACB), Pulmonx (LUNG)April 10, 2025 | markets.businessinsider.comPulmonx Co. (NASDAQ:LUNG) Shares Sold by Pura Vida Investments LLCPura Vida Investments LLC trimmed its holdings in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 24.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 387,200 shares of the company's stock after selling 122,575 sharesMarch 31, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesPulmonx Co. (NASDAQ:LUNG - Get Free Report) has received an average rating of "Moderate Buy" from the nine research firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendationMarch 28, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Director Glendon E. French III Sells 20,000 SharesPulmonx Co. (NASDAQ:LUNG - Get Free Report) Director Glendon E. French III sold 20,000 shares of Pulmonx stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $7.85, for a total transaction of $157,000.00. Following the completion of the transaction, the director now directly owns 991,974 shares in the company, valued at approximately $7,786,995.90. This represents a 1.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.March 22, 2025 | marketbeat.comGlendon E. French III Sells 20,000 Shares of Pulmonx Co. (NASDAQ:LUNG) StockMarch 22, 2025 | insidertrades.comPrimecap Management Co. CA Reduces Holdings in Pulmonx Co. (NASDAQ:LUNG)Primecap Management Co. CA reduced its holdings in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 2.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,512,291 shares of the company's stock after selliMarch 19, 2025 | marketbeat.comD. Boral Capital Initiates Coverage of Pulmonx (LUNG) with Buy RecommendationMarch 11, 2025 | msn.comPulmonx (NASDAQ:LUNG) Now Covered by Analysts at D. Boral CapitalD. Boral Capital initiated coverage on Pulmonx in a report on Monday. They set a "buy" rating and a $17.00 target price on the stock.March 10, 2025 | marketbeat.comPulmonx initiated with a Buy at D. Boral CapitalMarch 10, 2025 | markets.businessinsider.comLake Street Keeps Their Buy Rating on Pulmonx (LUNG)March 8, 2025 | markets.businessinsider.comLake Street Keeps Their Buy Rating on Pulmonx (LUNG)March 8, 2025 | markets.businessinsider.comPulmonx Co. (NASDAQ:LUNG) CFO Mehul Joshi Sells 14,384 SharesPulmonx Co. (NASDAQ:LUNG - Get Free Report) CFO Mehul Joshi sold 14,384 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $7.12, for a total transaction of $102,414.08. Following the transaction, the chief financial officer now directly owns 113,986 shares of the company's stock, valued at $811,580.32. The trade was a 11.21 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.March 6, 2025 | marketbeat.comSteven S. Williamson Sells 27,689 Shares of Pulmonx Co. (NASDAQ:LUNG) StockPulmonx Co. (NASDAQ:LUNG - Get Free Report) CEO Steven S. Williamson sold 27,689 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $7.14, for a total value of $197,699.46. Following the completion of the sale, the chief executive officer now owns 194,342 shares in the company, valued at approximately $1,387,601.88. This represents a 12.47 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.March 6, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Insider Geoffrey Beran Rose Sells 5,779 SharesPulmonx Co. (NASDAQ:LUNG - Get Free Report) insider Geoffrey Beran Rose sold 5,779 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $7.13, for a total transaction of $41,204.27. Following the transaction, the insider now owns 285,278 shares in the company, valued at approximately $2,034,032.14. This trade represents a 1.99 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.March 6, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) General Counsel David Aaron Lehman Sells 22,355 SharesPulmonx Co. (NASDAQ:LUNG - Get Free Report) General Counsel David Aaron Lehman sold 22,355 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $7.65, for a total value of $171,015.75. Following the completion of the sale, the general counsel now directly owns 175,496 shares of the company's stock, valued at $1,342,544.40. The trade was a 11.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.March 6, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Insider Geoffrey Beran Rose Sells 5,779 SharesMarch 6, 2025 | insidertrades.comEDAP Appoints Glen French to Board of DirectorsMarch 3, 2025 | globenewswire.comPulmonx Co. (NASDAQ:LUNG) Given Consensus Rating of "Moderate Buy" by BrokeragesPulmonx Co. (NASDAQ:LUNG - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to tMarch 3, 2025 | marketbeat.comCiti Reaffirms Their Hold Rating on Pulmonx (LUNG)February 28, 2025 | markets.businessinsider.comPulmonx management to meet virtually with Lake StreetFebruary 27, 2025 | markets.businessinsider.comPulmonx Co. (NASDAQ:LUNG) Director Sells $459,150.84 in StockPulmonx Co. (NASDAQ:LUNG - Get Free Report) Director Glendon E. French III sold 55,453 shares of Pulmonx stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $8.28, for a total value of $459,150.84. Following the completion of the transaction, the director now owns 1,011,974 shares in the company, valued at approximately $8,379,144.72. The trade was a 5.20 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.February 25, 2025 | marketbeat.comInsider Selling: Pulmonx Co. (NASDAQ:LUNG) Director Sells 55,453 Shares of StockFebruary 25, 2025 | insidertrades.comPulmonx Corporation: Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial ResultsFebruary 21, 2025 | finanznachrichten.dePulmonx (LUNG) Gets a Buy from Piper SandlerFebruary 21, 2025 | markets.businessinsider.com Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address LUNG Media Mentions By Week LUNG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUNG News Sentiment▼-0.030.88▲Average Medical News Sentiment LUNG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUNG Articles This Week▼32▲LUNG Articles Average Week Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Semler Scientific News Today Treace Medical Concepts News Today ClearPoint Neuro News Today Outset Medical News Today Nano-X Imaging News Today Sanara MedTech News Today Nyxoah News Today Neuronetics News Today ZimVie News Today Nevro News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUNG) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmonx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LUNG Stock Free LUNG Stock Alerts